Publications by authors named "Debora Sternaman"

Claim this Profile
E
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Daniel S Bandari, Debora Sternaman, Theodore Chan, Chris R Prostko, Tamar Sapir

J Manag Care Pharm· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Risk Evaluation and Mitigation Strategy (REMS) programs for managed care pharmacy.

J Manag Care Pharm· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis